InMed Pharmaceuticals Inc.
INM
$2.12
-$0.23-9.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.34% | -36.79% | -24.60% | 2.26% | 3.42% |
| Total Depreciation and Amortization | -11.54% | -7.97% | -4.23% | 0.54% | 1.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -56.52% | 46.33% | 46.01% | 537.72% | -28.35% |
| Change in Net Operating Assets | 8.69% | 139.23% | 76.29% | 10.38% | 34.74% |
| Cash from Operations | -11.18% | -6.09% | -15.08% | 7.82% | 4.08% |
| Capital Expenditure | -- | 100.00% | 100.00% | 94.25% | 94.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 100.00% | 100.00% | 98.59% | 98.59% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 152.19% | -16.39% | -72.65% | 31.67% | -51.45% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -57.22% | 52.95% | 55.64% | -231.98% | -- |
| Cash from Financing | 163.66% | -11.97% | -74.36% | 4.59% | -56.42% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 292.41% | -45.79% | -218.91% | 55.77% | -185.57% |